The estimated Net Worth of Ray Kurzweil is at least $5.07 million dollars as of 13 July 2024. Mr. Kurzweil owns over 900 units of United Therapeutics Corp stock worth over $4,181,975 and over the last 20 years he sold UTHR stock worth over $472,237. In addition, he makes $411,740 as Independent Director at United Therapeutics Corp.
Sign up
Mr. Kurzweil UTHR stock SEC Form 4 insiders trading
Raymond has made over 29 trades of the United Therapeutics Corp stock since 2005, according to the Form 4 filled with the SEC. Most recently he exercised 900 units of UTHR stock worth $311,571 on 13 July 2024.
The largest trade he's ever made was exercising 30,000 units of United Therapeutics Corp stock on 9 August 2022 worth over $4,246,200. On average, Raymond trades about 5,854 units every 151 days since 2005. As of 13 July 2024 he still owns at least 12,080 units of United Therapeutics Corp stock.
You can see the complete history of Mr. Kurzweil stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Raymond Kurzweil biography
Raymond C. Kurzweil J.D. serves as Independent Director of the Company. Mr. Kurzweil is an inventor, entrepreneur and author, and has created several important technologies in the artificial intelligence field. He has received the National Medal of Technology, the MIT Lemelson Prize, twenty-one honorary doctorates, a Grammy award for his contributions to music technology, and honors from three U.S. Presidents. In 2002, Mr. Kurzweil was inducted into the National Inventors Hall of Fame. Since 1995, Mr. Kurzweil has served as the Chief Executive Officer of Kurzweil Technologies, Inc., a technology development firm. Since January 2013, he has also served as a Director of Engineering for Google, a global technology and Internet search company. He has served as a United Therapeutics director since 2002.
What is the salary of Raymond Kurzweil?
As the Independent Director of United Therapeutics Corp, the total compensation of Raymond Kurzweil at United Therapeutics Corp is $411,740. There are 18 executives at United Therapeutics Corp getting paid more, with Martine Rothblatt having the highest compensation of $15,627,500.
How old is Raymond Kurzweil?
Raymond Kurzweil is 72, he's been the Independent Director of United Therapeutics Corp since 2002. There are 3 older and 17 younger executives at United Therapeutics Corp. The oldest executive at United Therapeutics Corp is Louis Sullivan, 86, who is the Independent Director.
What's Raymond Kurzweil's mailing address?
Ray's mailing address filed with the SEC is C/O UNITED THERAPEUTICS CORPORATION, 1000 SPRING STREET, SILVER SPRING, MD, 20910.
Insiders trading at United Therapeutics Corp
Over the last 20 years, insiders at United Therapeutics Corp have traded over $68,910,395 worth of United Therapeutics Corp stock and bought 229,703 units worth $13,655,671 . The most active insiders traders include Martine A Rothblatt, David Zaccardelli et Roger Jeffs. On average, United Therapeutics Corp executives and independent directors trade stock every 3 days with the average trade being worth of $2,310,818. The most recent stock trade was executed by James Edgemond on 9 September 2024, trading 8,332 units of UTHR stock currently worth $991,341.
What does United Therapeutics Corp do?
united therapeutics corporation is a biotechnology company focused on the development and commercialization of unique products to address the unmet medical needs of patients with chronic and life-threatening conditions. we currently have five approved products on the market, and a long-term mission of providing an unlimited supply of transplantable organs for those who need them! our employees can be found collaborating across the united states, europe and asia. as a group, we are relentless in our pursuit of “medicines for life” and continue to research and develop treatments for cardiovascular and pulmonary diseases, pediatric cancers, and other orphan diseases. #weareunitherians
What does United Therapeutics Corp's logo look like?
Complete history of Mr. Kurzweil stock trades at United Therapeutics Corp
United Therapeutics Corp executives and stock owners
United Therapeutics Corp executives and other stock owners filed with the SEC include:
-
Martine Rothblatt,
Chairman of the Board, Chief Executive Officer -
Michael Benkowitz,
President, Chief Operating Officer -
Paul Mahon,
Executive Vice President, General Counsel, Corporate Secretary -
James Edgemond,
Chief Financial Officer, Treasurer -
Dr. Martine A. Rothblatt J.D., M.B.A., Ph.D.,
Founder, Chairman & CEO -
Dr. Martine A. Rothblatt,
Founder, Chairman & CEO -
Michael I. Benkowitz,
Pres & COO -
Paul A. Mahon,
Exec. VP, Gen. Counsel & Corp. Sec. -
Paul A. Mahon J.D.,
Exec. VP, Gen. Counsel & Corp. Sec. -
James C. Edgemond,
CFO & Treasurer -
Christopher Patusky,
Lead Independent Vice Chairman of the Board -
Christopher Causey,
Independent Director -
Richard Giltner,
Independent Director -
Louis Sullivan,
Independent Director -
Tommy Thompson,
Independent Director -
Nilda Mesa,
Independent Director -
Judy Olian,
Independent Director -
Katherine Klein,
Independent Director -
Raymond Kurzweil,
Independent Director -
Raymond Dwek,
Independent Director -
Linda Maxwell,
Director -
Dewey Steadman C.F.A.,
Head of Investor Relations -
Leigh Peterson,
VP of Product Devel. -
Gil Golden,
Sr. VP & Chief Medical Officer -
Patrick Poisson,
Exec. VP of Technical Operations -
Kevin T. Gray,
Sr. VP of Strategic Operations & Logistics -
Holly Hobson,
Associate VP of HR -
Dewey Steadman C.F.A., CFA,
Head of Investor Relations -
Jan Malcolm,
-
Ray Kurzweil,
-
Roger Jeffs,
President & COO -
Fred T Hadeed,
EVP & CFO -
David Zaccardelli,
EVP & Chief Operating Officer -
John Maxim Ferrari,
CFO & Treasurer -
R Paul Gray,
Director -
Lilly & Co Eli,
Director, Chairman and CEO